Exact Mass: 354.1256

Exact Mass Matches: 354.1256

Found 18 metabolites which its exact mass value is equals to given mass value 354.1256, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-

C18H24Cl2N2O (354.1266)


   
   

3-[6-(ETHOXYCARBONYL)-3-ETHYL-2-METHYL-3H-BENZIMIDAZOL-1-IUM-1-YL]PROPANE-1-SULFONATE

3-[6-(ETHOXYCARBONYL)-3-ETHYL-2-METHYL-3H-BENZIMIDAZOL-1-IUM-1-YL]PROPANE-1-SULFONATE

C16H22N2O5S (354.1249)


   

3-(3-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(3-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N2O5S (354.1249)


   

3-(4-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-CARBAMOYL-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C16H22N2O5S (354.1249)


   

[1,1:3,1-Terphenyl]-4,4-diol,5-(4-hydroxyphenyl)-

[1,1:3,1-Terphenyl]-4,4-diol,5-(4-hydroxyphenyl)-

C24H18O3 (354.1256)


   

1-naphthylacetic anhydride

1-naphthylacetic anhydride

C24H18O3 (354.1256)


   

3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide

3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide

C18H24Cl2N2O (354.1266)


   

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, cis-

Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, cis-

C18H24Cl2N2O (354.1266)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

2-(3,4-Dichlorophenyl)-1-[2-(1-pyrrolidinylmethyl)-1-piperidinyl]ethanone

2-(3,4-Dichlorophenyl)-1-[2-(1-pyrrolidinylmethyl)-1-piperidinyl]ethanone

C18H24Cl2N2O (354.1266)


   

N-acetylmethionyltyrosine

N-acetylmethionyltyrosine

C16H22N2O5S (354.1249)


   

2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3S,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2S,3S,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3R,6S)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

2-[(2R,3R,6R)-3-(benzenesulfonamido)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N,N-dimethylacetamide

C16H22N2O5S (354.1249)


   

MLS1547

MLS1547

C19H19ClN4O (354.1247)


MLS1547 is a highly efficacious G protein-biased dopamine D2 receptor (D2R) agonist (Ki=1.2 μM). MLS1547 stimulates D2R G protein-mediated signaling (EC50=0.37 μM in a calcium mobilization assay). MLS1547 acts as an antagonist for dopamine (DA)-stimulated β-arrestin recruitment to the D2R (IC50=9.9 μM)[1][2].